This Viewpoint discusses possible outcomes of predictive analytic tool use in charity care determinations: hospital revenue and patient debt.
Risultati per: Terapia antibiotica: breve durata vs. lunga durata
Questo è quello che abbiamo trovato per te
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer
To the Editor A recent study reported on the absence of a statistically significant benefit of aspirin at 300 mg/d for recurrence and survival in patients with breast cancer. In accordance with these findings, the authors advised against the routine use of aspirin as an adjunct treatment in breast cancer.
Aspirin vs Placebo as Adjuvant Therapy for Breast Cancer—Reply
In Reply Alliance A011502, a randomized trial of aspirin 300 mg daily compared with placebo among 3020 survivors of high-risk nonmetastatic breast cancer, was terminated early due to lack of benefit from aspirin. Dr Thorat and colleagues note that for some cancers (eg, colorectal cancer) and different settings (eg, primary prevention), the time course of benefit can differ. However, in the adjuvant setting, it would still be most appropriate to use the standard stopping rules applied to adjuvant treatments such as hormonal therapy for hormone receptor–positive cancers, which, as Thorat and colleagues point out, can have a more indolent course with late recurrences. In our trial, the futility bound was crossed with a numerically worse hazard ratio for invasive disease–free survival (hazard ratio, 1.27; 95% CI, 0.99-1.63; P = .06), making it unlikely that a benefit would have been observed with further follow-up.
Terapia mirata per la colite ulcerosa
Terapia ormonale sostitutiva solo a 4% donne ma protegge anche dal diabete
Endocrinologi, troppi timori, non si spiegano bene i vantaggi
Continuation vs Discontinuation of RASIs Before Major Noncardiac Surgery
This randomized clinical trial compares the effect of continued use of renin-angiotensin system inhibitors (RASIs) vs discontinued use of RASIs before major noncardiac surgery on postoperative complications.
Tumori neuroendocrini, nuova terapia riduce rischio progressione
In aumento, un terzo dei pazienti riceve diagnosi dopo 5 anni
Tumori neuroendocrini, nuova terapia riduce rischio progressione
In aumento, un terzo dei pazienti riceve diagnosi dopo 5 anni
Psoriasi, ok alla rimborsabilità per una nuova terapia orale
Colpiti in 500mila, il farmaco è per forme moderate e severe
Psoriasi, ok alla rimborsabilità per una nuova terapia orale
Colpiti in 500mila, il farmaco è per forme moderate e severe
Tumore prostata, terapia riduce progressione o morte del 46%
Nella forma metastatica ormonosensibile
La terapia ormonale per la menopausa protegge il cuore
Ha effetti positivi sui grassi e gli zuccheri nel sangue
Safety of In Utero Exposure to Buprenorphine + Naloxone vs Buprenorphine Alone
This population-based cohort study uses health care utilization data for pregnant individuals with opioid use disorder to compare neonatal and maternal outcomes following prenatal exposure to buprenorphine combined with naloxone vs buprenorphine alone.
Al via sviluppo terapia genica fetale, farmaci per malattia rara
Sindrome di Leigh,progetto vincitore bando Multi-round Telethon
Terapia genica migliora la vista in pazienti con rara malattia
Per l’amaurosi congenita di Leber risultati duraturi e notevoli
Rimborsabile un nuovo tipo di terapia per la colite ulcerosa
Ok da Aifa, riduce i sintomi intestinali senza l’uso di steroidi